Clinical Trial Update: Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial in healthy Chinese adults aged 40 years and older evaluating a recombinant herpes zoster vaccine produced in CHO cells.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Recombinant herpes zoster vaccine (CHO cell) (recombinant herpes zoster vaccine)

Snippet

Sponsor: Ab&B Bio-tech Co., Ltd.JS | Conditions: Herpes Zoster, Herpes Zoster Vaccine | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING